The largest review ever conducted on opioids for acute pain found that these widely prescribed drugs often deliver only small,… Read More​ 

Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells.… Read More​ 

Once-daily oral elecoglipron showed reductions in glycaemia and a safety and tolerability profile consistent with the GLP-1 receptor agonist class… Read More​ 

Daily oral elecoglipron demonstrated clinically meaningful weight reductions and a safety and tolerability profile consistent with the GLP-1 receptor agonist… Read More​ 

Obesity and type 2 diabetes are closely connected chronic progressive diseases that require an integrated prevention and treatment approach, ranging… Read More​ 

A major long-term study of more than 54,000 adults found that where nitrate comes from may matter far more than… Read More​ 

A trio of major studies found that finerenone may protect the kidneys and heart in far more people than previously… Read More​ 

A traditional Chinese medicinal root used for over a thousand years is attracting new scientific attention for its potential to… Read More​ 

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about… Read More​ 

Supplements are often marketed as shortcuts to better health, but for many older adults, the real issue is whether they… Read More​ 

Scientists warn that free-living amoebae may be an underappreciated public health threat, capable of causing deadly infections and shielding other… Read More​ 

Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to be safe… Read More​ 

Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2… Read More​ 

In the studied populations with CKD, finerenone reduced the risk of CKD progression, including kidney failure alone, and reduced heart… Read More​ 

Chronic kidney disease (CKD) causes one death every 20 seconds.1 CKD ranks among the fastest growing global causes of death,… Read More​ 

The current outbreak of Ebola virus disease caused by Bundibugyo virus in DR Congo and Uganda is not only a… Read More​ 

The 2026 outbreak of Ebola virus disease in DR Congo and Uganda, caused by Bundibugyo virus (Orthoebolavirus bundibugyoense), represents one… Read More​ 

A major review of nearly 8,000 participants found that collagen supplements can improve skin health and ease osteoarthritis symptoms, especially… Read More​ 

This exploratory analysis of a randomized clinical trial evaluates the efficacy and safety of finerenone in reducing chronic kidney disease… Read More​ 

A large study of older adults in Brazil found that adding extra salt at the table is still a common… Read More​ 

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug,… Read More​ 

Atrasentan reduced proteinuria and preserved kidney function after 2·5 years. This effect was present with or without concomitant SGLT2 inhibitor… Read More​ 

Endothelin biology remains an attractive therapeutic target in IgA nephropathy where intrarenal endothelin-1 expression is upregulated and implicated in nephron… Read More​ 

A newly discovered genetic clock acts as the master timekeeper for development, orchestrating crucial bursts of gene activity throughout a… Read More​ 

On May 17, 2026, WHO determined the Ebola virus disease in the Democratic Republic of the Congo a Public Health… Read More​ 

The Bundibugyo virus (Orthoebolavirus bundibugyoense) outbreak in DR Congo has already registered over 300 confirmed cases, including more than 40… Read More​ 

Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided immunology… Read More​ 

This study evaluates associations between major clinical outcomes and measured glomerular filtration rate (GFR), estimated GFR (eGFR) for plasma creatinine,… Read More​ 

This randomized clinical trial examines the safety and efficacy of low-dose rivaroxaban in the treatment of patients with advanced chronic… Read More​ 

Data pubblicazione: 2026-05-28 Read More​ 

Data ultimo aggiornamento: 2026-05-29 Read More​ 

Data ultimo aggiornamento: 2026-05-29 Read More​ 

A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far… Read More​ 

Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic.… Read More​ 

A newly identified group of amygdala neurons appears to play a central role in anxiety and social behavior. Restoring normal… Read More​ 

Chronic kidney disease (CKD) is increasingly recognised as a complex, multisystem condition that rarely occurs in isolation. This Series paper… Read More​ 

Biological differences exist between males and females in kidney structure and function, leading to sex heterogeneity in the presentation and… Read More​ 

Chronic kidney disease affects 788–844 million adults worldwide and is projected to become the fifth leading cause of death by… Read More​ 

French fries may be the real potato problem. A large study tracking more than 205,000 people for nearly 40 years… Read More​ 

Scientists have uncovered evidence that autism may include at least two biologically distinct subtypes, each marked by a different pattern… Read More​